Company in alleged generic drugs cartel pays undisclosed sum to NHSBMJ 2010; 340 doi: http://dx.doi.org/10.1136/bmj.c1225 (Published 02 March 2010) Cite this as: BMJ 2010;340:c1225
- Clare Dyer
Kent Pharmaceuticals has agreed to pay the health service an undisclosed sum as the latest settlement in a long running civil action against generic drug manufacturers. The companies had been accused of operating an illegal cartel to fix the price of their products, depriving the NHS of tens of millions of pounds.
Kent’s agreement to pay without admitting liability follows three sets of claims launched between 2002 and 2004 against eight companies that were accused of depriving the NHS of more than £150m (€170m; $225m). Five others, …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial